Adsorption material for blood filtration and preparation method thereof
By using microwave and ultraviolet light in adsorbent materials, combined with components such as flower-like titanium dioxide and silk fibroin, the problem of using hazardous coupling agents in the modification process of existing adsorbents is solved, achieving efficient and stable Adsorption effect and good blood compatibility.
Patent Information
- Application Number
- CN202410196907.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-22
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-02-22
AI Technical Summary
The existing adsorbents inevitably introduce potentially harmful coupling agents during the modification and modification process, and the coupling ligand efficiency is not high, resulting in unstable product performance and large batch-to-batch differences.
Using microwave and ultraviolet illumination methods, the floral titanium dioxide, silk fibroin, riboflavin and polymyxin B are crosslinked on the carrier, and the materials are improved by tannin acid and aminopropyltriethoxysilane. The hydrophilic properties of the cell inflammatory factors can be better adsorbed, avoiding the use of additional coupling agents.
It realizes efficient, stable and safe preparation of adsorbent materials, simple operation and low equipment requirements, avoids the use of toxic crosslinking agents, improves the uniformity and continuity of adsorbent materials, and reduces incompatibility to blood.
Smart Images

Figure CN117839640B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of adsorption materials and discloses an adsorption material for blood filtration and a preparation method thereof. Background Art
[0002] Severe acute pancreatitis (SAP) is a common and critical disease in clinical practice. In the early stage of the disease, it can lead to increased vascular permeability, causing a large amount of substances to enter the abdominal cavity, resulting in peritoneal effusion, which in turn damages organs such as the kidneys and intestines, leading to a vicious cycle of severe acute pancreatitis. At present, hemofiltration is commonly used in clinical practice to treat severe acute pancreatitis. Hemofiltration is a blood purification technology that uses the convection principle to remove solutes. It can slowly and continuously remove a variety of inflammatory cytokines through adsorption materials.
[0003] Adsorption materials for blood filtration include three categories: activated carbon, inorganic porous materials and organic polymer materials. Since the molecular weight of cellular inflammatory factors is large, the adsorption effect of broad-spectrum adsorbents is not ideal and the selectivity is poor. The general method is to modify and modify the skeleton of the adsorbent to achieve the effect of specific adsorption. The main methods used are photoinitiated polymerization, plasma flow chemical deposition, thiol-ene click reaction, etc.
[0004] For example, patent CN104959120A couples acetylated cysteine on the surface of the carrier through an amino linker arm to remove cellular inflammatory factors. However, the modification, modification and coupling of the adsorbent skeleton inevitably introduce coupling agents that are potentially harmful to the human body. At the same time, due to the epoxidation and subsequent coupling of the ligand, the efficiency of the coupling ligand is not high, and there is a risk of falling off and entering the human body. The prior art also uses epichlorohydrin and carbonyldiimidazole as coupling reagents to activate the carrier to couple PMB (polymyxin B). Although the use of highly toxic cyanogen bromide is avoided, the preparation process has many reaction steps and requires five chemical reactions to synthesize the adsorbent material. This type of method is complicated, and the resulting adsorbent product has large batch differences and unstable performance. Summary of the invention
[0005] The technical problem to be solved by the present invention is that the coupling agent is used to modify and alter the skeleton of the adsorbent, which inevitably introduces the coupling agent that is potentially harmful to the human body. At the same time, due to the epoxidation and then coupling ligand, the efficiency of the coupling ligand is not high, and there is a risk of falling off and entering the human body.
[0006] In order to solve the above technical problems, the present invention provides an adsorption material for blood filtration and a preparation method thereof.
[0007] In one aspect, the present invention provides a method for preparing an adsorption material for blood filtration, comprising: soaking a carrier in acetone, anhydrous ethanol and water in sequence, then placing the carrier in a first mixed liquid, microwaved and then allowed to stand, irradiated with ultraviolet light, then placed in a second mixed liquid, and dried to obtain the adsorption material;
[0008] The first mixed solution includes flower-shaped titanium dioxide, silk fibroin, riboflavin, and polymyxin B;
[0009] The second mixed solution includes tannic acid, tris(hydroxymethyl)aminomethane hydrochloride, and aminopropyltriethoxysilane.
[0010] Furthermore, in the method for preparing the adsorption material for blood filtration described in the present invention, the first mixed solution includes 10~50 mg / mL flower-shaped titanium dioxide, 50~100 mg / mL silk fibroin, 0.1~0.2 mmol / L riboflavin, and 40~80 mg / mL polymyxin B.
[0011] Furthermore, in the preparation method of the adsorbent material for blood filtration of the present invention, the second mixed solution includes 2-5 mg / mL tannic acid, 0.1 mol / L tris(hydroxymethyl)aminomethane hydrochloride, and 2-5 mg / mL aminopropyltriethoxysilane. The present invention uses tannic acid and aminopropyltriethoxysilane to provide the hydrophilicity of the material, so that during blood filtration, cellular inflammatory factors pass through the surface of the material and gather in the center of the flower-shaped titanium dioxide, which can be better affinity with polymyxin B.
[0012] Furthermore, in the method for preparing an adsorbent material for blood filtration of the present invention, the pH of the second mixed solution is 7.5-8.5.
[0013] Furthermore, in the method for preparing the adsorption material for blood filtration described in the present invention, the carrier is selected from one of a polystyrene fiber membrane, a polyglycolic acid membrane, and a hollow fiber braided tube.
[0014] Furthermore, in the preparation method of the adsorbent material for blood filtration of the present invention, the flower-shaped titanium dioxide is composed of titanium dioxide nanosheets with a particle size of 200-300 nm. The present invention utilizes the unique structural characteristics of the flower-shaped titanium dioxide to provide a skeleton support for the composite structure and provide a certain hydrophobic property.
[0015] Furthermore, in the preparation method of the adsorbent material for blood filtration of the present invention, the power of the microwave is 50-300 W, and the microwave time is 5-10 min. The present invention adopts microwaves and uses flower-shaped titanium dioxide as an energy absorbing material, so that the components of the first mixed solution can be better compounded with the carrier in the subsequent steps.
[0016] Furthermore, in the preparation method of the adsorbent material for blood filtration of the present invention, the standing time is 30 to 60 minutes, and the ultraviolet irradiation time is 30 to 60 minutes. The present invention utilizes the cross-linking property of silk fibroin and riboflavin under ultraviolet irradiation to compound polymyxin B with the carrier after surface modification by alcohol solution.
[0017] On the other hand, the present invention relates to an adsorption material for blood filtration, which is prepared by the above-mentioned preparation method of the adsorption material for blood filtration.
[0018] Compared with the prior art, the technical solution provided by the present invention has at least the following beneficial effects or advantages:
[0019] (1) The preparation method provided by the present invention does not require additional grafting of functional groups on the surface of the carrier and then connecting functional ligands, thus avoiding the technical problem of commonly used cross-linking agents or coupling agents that are usually toxic. The preparation method is simple and efficient to operate, has low equipment requirements, and mild reaction conditions.
[0020] (2) The preparation method provided by the present invention adopts an interpenetrating network approach and utilizes riboflavin to cross-link silk fibroin to fix polymyxin B in the adsorption material, with good uniformity, continuity and stability.
[0021] (3) The present invention uses a hydrophilic substance in combination with flower-shaped titanium dioxide to give the adsorption material good asymmetric cooperative wettability, less adsorption of total protein, fibrinogen and albumin in the blood, less adhesion to blood cells, and good blood compatibility. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the description are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0023] Figure 1 It is a bar graph showing the clearance rate of cellular inflammatory factors by the adsorbent. DETAILED DESCRIPTION
[0024] The technical scheme of the present invention is described below in conjunction with the embodiments, but the present invention is not limited to the following embodiments. The experimental methods and detection methods described in each embodiment are conventional methods unless otherwise specified; the reagents and materials described are all commercially available unless otherwise specified.
[0025] Example 1
[0026] This embodiment provides a method for preparing an adsorption material for blood filtration.
[0027] Preparation of the first mixed solution: 50 g of silk fibroin (purchased from Suzhou Simet Biotechnology Co., Ltd.) was dissolved in hexafluoroisopropanol to obtain a 20% silk fibroin solution. The silk fibroin solution, 10 g of flower-shaped titanium dioxide (purchased from Hefei Kejing Material Technology Co., Ltd., the flower-shaped titanium dioxide is composed of titanium dioxide nanosheets with a particle size of 200-300 nm), 0.1 mmol riboflavin, and 40 g of polymyxin B were dispersed in deionized water, fixed to 1 L, mixed evenly, and packaged.
[0028] Preparation of the second mixed solution: Mix 2g of tannic acid, 2g of aminopropyltriethoxysilane and 0.1mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH=8), make the volume to 1L with 0.1mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH=8), adjust the pH of the second mixed solution to 8 with hydrochloric acid or sodium hydroxide, mix well and package.
[0029] A polystyrene fiber membrane (pore size 30 μm, purchased from Xi'an Qiyue Biotechnology Co., Ltd.) was immersed in a beaker filled with acetone and placed in an ultrasonic cleaner for 30 minutes. The polystyrene fiber membrane was taken out and immersed in a beaker filled with anhydrous ethanol and placed in an ultrasonic cleaner for 30 minutes. The polystyrene fiber membrane was taken out and immersed in a beaker filled with deionized water and placed in an ultrasonic cleaner for 30 minutes. After being taken out, it was immersed in a beaker filled with the first mixed solution, microwaved at 50 W for 5 minutes, allowed to stand at room temperature for 30 minutes, irradiated with ultraviolet light for 30 minutes, immersed in a beaker filled with the second mixed solution and allowed to stand for 30 minutes. The polystyrene fiber membrane was not taken out, and was vacuum dried together with the beaker, and then thoroughly washed with anhydrous ethanol and water to obtain an adsorption material.
[0030] Example 2
[0031] This example provides the preparation of an adsorbent material for blood filtration.
[0032] Preparation of the first mixed solution: 70 g of silk fibroin (purchased from Suzhou Simet Biotechnology Co., Ltd.) was dissolved in hexafluoroisopropanol to obtain a 20% silk fibroin solution. The silk fibroin solution, 30 g of flower-shaped titanium dioxide (purchased from Hefei Kejing Material Technology Co., Ltd., the flower-shaped titanium dioxide is composed of titanium dioxide nanosheets with a particle size of 200-300 nm), 0.15 mmol of riboflavin, and 60 g of polymyxin B were dispersed in deionized water, fixed to 1 L, mixed evenly, and then packaged.
[0033] Preparation of the second mixed solution: Mix 3g of tannic acid, 3g of aminopropyltriethoxysilane and 0.1mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH=8), make the volume to 1L with 0.1mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH=8), adjust the pH of the second mixed solution to 8 with hydrochloric acid or sodium hydroxide, mix well and package.
[0034] A polystyrene fiber membrane (pore size 30 μm, purchased from Xi'an Qiyue Biotechnology Co., Ltd.) was immersed in a beaker filled with acetone and placed in an ultrasonic cleaner for 30 minutes. The polystyrene fiber membrane was taken out and immersed in a beaker filled with anhydrous ethanol and placed in an ultrasonic cleaner for 30 minutes. The polystyrene fiber membrane was taken out and immersed in a beaker filled with deionized water and placed in an ultrasonic cleaner for 30 minutes. After being taken out, it was immersed in a beaker filled with the first mixed solution, microwaved at 100 W for 8 minutes, allowed to stand at room temperature for 40 minutes, irradiated with ultraviolet light for 40 minutes, immersed in a beaker filled with the second mixed solution and allowed to stand for 30 minutes. The polystyrene fiber membrane was not taken out, and after vacuum drying together with the beaker, it was soaked in pH 8.0, 0.1 mol / L Tris-HCl at 25°C for reaction for 12 hours to block the excess active groups on the matrix, and was fully washed with anhydrous ethanol and water to obtain the adsorption material.
[0035] Example 3
[0036] This example provides the preparation of an adsorbent material for blood filtration.
[0037] Preparation of the first mixed solution: 100 g of silk fibroin (purchased from Suzhou Simet Biotechnology Co., Ltd.) was dissolved in hexafluoroisopropanol to obtain a 20% silk fibroin solution. The silk fibroin solution, 50 g of flower-shaped titanium dioxide (purchased from Hefei Kejing Material Technology Co., Ltd., the flower-shaped titanium dioxide is composed of titanium dioxide nanosheets with a particle size of 200-300 nm), 0.2 mmol riboflavin, and 80 g of polymyxin B were dispersed in deionized water, fixed to 1 L, mixed evenly, and packaged.
[0038] Preparation of the second mixed solution: Mix 5g of tannic acid, 5g of aminopropyltriethoxysilane and 0.1mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH=8), make the volume to 1L with 0.1mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH=8), adjust the pH of the second mixed solution to 8 with hydrochloric acid or sodium hydroxide, mix well and package.
[0039] A polystyrene fiber membrane (pore size 30 μm, purchased from Xi'an Qiyue Biotechnology Co., Ltd.) was immersed in a beaker filled with acetone and placed in an ultrasonic cleaner for 30 minutes. The polystyrene fiber membrane was taken out and immersed in a beaker filled with anhydrous ethanol and placed in an ultrasonic cleaner for 30 minutes. The polystyrene fiber membrane was taken out and immersed in a beaker filled with deionized water and placed in an ultrasonic cleaner for 30 minutes. After being taken out, it was immersed in a beaker filled with the first mixed solution, microwaved at 300 W for 10 minutes, allowed to stand at room temperature for 60 minutes, irradiated with ultraviolet light for 60 minutes, immersed in a beaker filled with the second mixed solution and allowed to stand for 30 minutes. The polystyrene fiber membrane was not taken out, and after vacuum drying together with the beaker, it was soaked in pH 8.0, 0.1 mol / L Tris-HCl at 25°C for reaction for 12 hours to block the excess active groups on the matrix, and was fully washed with anhydrous ethanol and water to obtain the adsorption material.
[0040] Comparative Example 1
[0041] This comparative example is the same as Example 2, except that microwaves were not used.
[0042] Comparative Example 2
[0043] This comparative example is the same as Example 2, except that ordinary titanium dioxide (purchased from Hefei Kejing Material Technology Co., Ltd., with a particle size of 200-300 nm) is used to replace the flower-shaped titanium dioxide.
[0044] Comparative Example 3
[0045] This comparative example is the same as Example 2, except that the second mixed solution does not contain tannic acid.
[0046] Comparative Example 4
[0047] The preparation method is the same as Example 1 in CN115845822A.
[0048] Example 4
[0049] This example provides an adsorption experiment of cellular inflammatory factors by the adsorbents prepared in Examples 1 to 3 and Comparative Examples 1 to 4.
[0050] Take a pyrogen-free test tube, add 0.5g of the adsorbent prepared in the example and the control example, respectively, and then add 2mL of plasma containing 140.3pg / mL of inflammatory factors interleukin-6 (IL-6) and 336.4pg / mL of tumor necrosis factor (TNF-α), respectively, and place it in a constant temperature water oscillator at (37±1)℃ and (100±10)rpm for 2h, then detect the concentrations of IL-6 and TNF-α, and calculate the decrease rate (%) of IL-6 and TNF-α before and after adsorption. The test results are shown in the figure. Figure 1 shown.
[0051] Depend on Figure 1 It can be seen that the adsorbent prepared by the present invention has a high adsorption rate for both inflammatory factors, which is much better than the adsorbent provided in Comparative Example 4, and the adjustment of conditions such as microwave, flower-shaped titanium dioxide or tannic acid will have a significant adverse effect on the adsorption effect.
[0052] Example 5
[0053] This example provides a hemolysis test of the adsorbents prepared in Examples 1 to 3 and Comparative Examples 1 to 4.
[0054] The hemolysis rate of the adsorbent was evaluated according to GB / T16886.4-2003 “Biological evaluation of medical devices Part 4: Selection of tests for interaction with blood”. The test results are shown in Table 1.
[0055] Table 1 Hemolysis rate of adsorbent
[0056] Hemolysis rate (%) Example 1 0.5 Example 2 0.8 Example 3 0.7 Comparative Example 1 0.5 Comparative Example 2 0.6 Comparative Example 3 0.5 Comparative Example 4 3.8
[0057] As can be seen from Table 1, the hemolysis rates of the adsorbents provided by the present invention are all lower than 1%, meeting the requirement of 5%. The adsorbent provided in Comparative Example 4 has a much higher hemolysis rate than the present invention due to the preparation method of grafting alkyl methacrylate and then epoxidation reaction.
[0058] The embodiments described above are part of the embodiments of the present invention, but not all of them. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but merely represents selected embodiments of the present invention. All other embodiments obtained without creative work and related deductions and substitutions made by ordinary technicians in the field under the conditions of the concept of the present invention belong to the scope of protection of the present invention.
Claims
1. A method for preparing an adsorbent material for blood filtration, characterized in that: include: The carrier is sequentially soaked in acetone, anhydrous ethanol and water, then placed in a first mixed solution, microwaved and allowed to stand, irradiated with ultraviolet light and placed in a second mixed solution, and dried to obtain the adsorption material; The first mixed solution includes flower-shaped titanium dioxide, silk fibroin, riboflavin and polymyxin B; The second mixed solution includes tannic acid, tris(hydroxymethyl)aminomethane hydrochloride and aminopropyltriethoxysilane; The carrier is selected from one of a polystyrene fiber membrane, a polyglycolic acid membrane, and a hollow fiber braided tube; The flower-shaped titanium dioxide is composed of titanium dioxide nanosheets, and the particle size is 200-300nm.
2. The method for preparing an adsorbent material for blood filtration according to claim 1, characterized in that: The first mixed solution includes 10-50 mg / mL flower-shaped titanium dioxide, 50-100 mg / mL silk fibroin, 0.1-0.2 mmol / L riboflavin and 40-80 mg / mL polymyxin B.
3. The method for preparing an adsorbent material for blood filtration according to claim 1, characterized in that: The second mixed solution includes 2-5 mg / mL tannic acid, 0.1 mol / L tris(hydroxymethyl)aminomethane hydrochloride and 2-5 mg / mL aminopropyltriethoxysilane.
4. The method for preparing an adsorbent material for blood filtration according to claim 3, characterized in that: The pH of the second mixed solution is 7.5-8.
5.
5. The method for preparing an adsorbent material for blood filtration according to claim 1, characterized in that: The power of the microwave is 50-300W, and the microwave time is 5-10min.
6. The method for preparing an adsorbent material for blood filtration according to claim 1, characterized in that: The standing time is 30 to 60 minutes, and the ultraviolet light irradiation time is 30 to 60 minutes.
7. An adsorbent material for blood filtration, characterized in that: The adsorbent material is prepared by the method for preparing the adsorbent material for blood filtration according to any one of claims 1 to 6.
Citation Information
Patent Citations
Inflammatory factor adsorbing agent for blood perfusion and preparation method
CN104959120A
Adsorbing material for removing blood cell factors and preparation method thereof
CN115845822A
Amphiphilic triblock copolymer, preparation method thereof, and polyethersulfone hollow fiber membrane blend-modified by using amphiphilic triblock copolymer
CN102432782A
Chemical crosslinking hydrogel and microsphere, and preparation method and application thereof
CN113549227A
Filter material for benzene-series waste gas and preparation method of filter material
CN117019118A
